Home » Topics » Disease categories and therapies » Infection

Infection
RSS

NC-1175 possesses ATPase-targeted antifungal activity

Jan. 10, 2000

Merck describes novel penems with activity against resistant staphylococci

Jan. 10, 2000

CRL-1072 enhances antibiotic activity against MAI

Jan. 10, 2000

Japanese investigators prepare new agents for influenza

Jan. 5, 2000

Total synthesis, structure reported for antifungal antibiotics produced by Penicillium

Jan. 4, 2000

Miltefosine tested as oral treatment for leishmaniasis

Jan. 4, 2000

ViroPharma licenses Battelle's drug delivery technology for its anti-RSV products

Jan. 3, 2000

Japanese approval obtained for Relenza

Dec. 30, 1999

Vitex receives milestone investment for progress with Inactine

Dec. 30, 1999

Aventis receives first product approval: E.U. grants approval of Synercid

Dec. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...